Measuring leprosy-related stigma - a pilot study to validate a toolkit of instruments.
Rensen C, Bandyopadhyay S, Gopal PK, van Brakel WH. Disability and rehabilitation. 2011; 33(9):711-9.
Evaluation of activity limitation and social participation, and the effects of reconstructive surgery in people with disability due to leprosy: a prospective cohort study.
Van Veen NH, Hemo DA, Bowers RL, Pahan D, Negrini J-, Velema JP, et al.. Disability and rehabilitation. 2011; 33(8):667-74.
The impact of leprosy on health-related quality of life.
Lustosa A, Nogueira L, Pedrosa J, Teles J, Campelo V. Revista da Sociedade Brasileira de Medicina Tropical. 2011; 44(5):621-6.
Perceived social restriction in leprosy-affected inhabitants of a former leprosy colony in northeast Brazil.
Lesshafft H, Heukelbach J, Barbosa J, Rieckmann N, Liesenfeld O, Feldmeier H. Leprosy review. 2010; 81(1):69-78.
Impacts of the diagnosis of leprosy and of visible impairments amongst people affected by leprosy in Cebu, the Philippines.
Boku N, Lockwood DN, Balagon M, Pardillo F, Maghanoy AA, Mallari IB, et al.. Leprosy review. 2010; 81(2):111-20.
Participation level of the leprosy patients in society.
Singh S, Sinha AK, Banerjee BG, Jaswal N. Indian journal of leprosy. 2009; 81(4):181-7.
Approaches and tools for measuring disability in low and middle-income countries.
van Brakel WH, Officer A. Leprosy review. 2008; 79(1):50-64.
Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
Gorouhi F, Solhpour A, Beitollahi J, Afshar S, Davari P, Hashemi P, et al.. Journal of the American Academy of Dermatology. 2007; 57(5):806-13.
Monitoring impairment in leprosy: choosing the appropriate tool.
Ebenso J, Ebenso BE. Leprosy review. 2007; 78(3):270-80.
The brief illness perception questionnaire.
Broadbent E, Petrie KJ, Main J, Weinman J. Journal of psychosomatic research. 2006; 60(6):631-7.
Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.